Clinical trial
A Randomised, Double-blind, Double-dummy, Parallel-group, Single Dose, Active and Placebo-controlled Efficacy and Pharmacokinetics/Pharmacodynamics Study of 2 x 200 mg Ibuprofen Liquid Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.
NCT05484401 is registered in ClinicalTrials.gov with Reckitt Benckiser Healthcare (UK) Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Double-dummy, Parallel-group, Single Dose, Active and Placebo-controlled Efficacy and Pharmacokinetics/Pharmacodynamics Study of 2 x 200 mg Ibuprofen Liquid Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.
- Lead sponsor
- Reckitt Benckiser Healthcare (UK) Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 9, 2022
- Completion date
- June 15, 2023
- Enrollment
- 294 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.